In the UK, former TNS and Kantar Health researcher Hazel Haskayne has joined the primary MR division of healthcare specialist Purdie Pascoe, as a Director.
The company was established fifteen years ago by former Synovate Healthcare Execs Marianne Purdie and Guy Pascoe, and offers full service MR for the sector, with offices in the UK, Canada and the USA.
Haskayne (pictured) joins with more than 25 years of experience in healthcare market research, including senior positions at Oracle Health & Life Sciences and Wimbledon-based Engage Research. Most recently she was Qual Practice Leader for Europe at Cerner Enviza, known until 2021 as Kantar Health, and earlier she spent fifteen years at TNS. Her knowledge spans multiple therapy areas, including deep expertise in oncology and rare diseases.
In her new role she will work closely with Purdie Pascoe's global primary market research teams to nurture existing client partnerships, enhance the firm's pharma services and boost its recognition within the market. Director Stephen Potts comments: 'I am delighted to welcome Hazel to the team. She is a market research expert with significant experience in the industry and brings a wealth of knowledge to the business. I look forward to collaborating with Hazel to strengthen our pharma market research offerings and deliver the best possible insights for our valued clients'.
The firm is online at www.purdiepascoe.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online